恩华药业: 江苏恩华药业股份有限公司监事会关于2024年限制性股票激励计划授予的限制性股票第一个解除限售期解除限售条件成就相关事项的核查意见

Core Points - The supervisory board of Jiangsu Enhua Pharmaceutical Co., Ltd. has verified that the conditions for the first unlock period of the 2024 restricted stock incentive plan have been met [1] - A total of 750 individuals are eligible for the unlocking of 2,264,451 shares of restricted stock [1] - The board of directors will proceed with the necessary actions to unlock the shares in accordance with the authorization from the first extraordinary general meeting of shareholders in 2024 [1] Summary by Sections - Verification of Conditions: The supervisory board confirmed that neither the company nor the incentive recipients faced any restrictions preventing the unlocking of the restricted stock [1] - Eligible Recipients: The number of eligible recipients for the unlocking of restricted stock is 750, with a total of 2,264,451 shares available for unlocking [1] - Board Approval Process: The board of directors conducted the review of related proposals with associated directors abstaining from voting, ensuring compliance with relevant laws and regulations [1]